Latest News

August 24, 2014
When urologist Peter Carroll, MD, MPH, did his residency at UCSF 30 years ago, cancer was “a word that was whispered,” a knowledgeable patient was someone who just followed doctor’s orders and oftentimes a diagnosis wasn’t made until disease was advanced.
February 04, 2014
Researchers are harnessing the power of the body's natural defenses to fight deadly cancers, and the treatment appears to be powerful, effective and long-lasting.
January 09, 2014
Scientists have discovered a type of RNA that could have enormous potential for better diagnosing and treating many types of cancer, Alzheimer's, multiple sclerosis and other diseases.
December 11, 2012
President Barack Obama announced his intent to nominate UCSF's Mack Roach, who is recognized as a major authority on the treatment of prostate cancer, to the National Cancer Advisory Board.
October 25, 2011
New studies of vitamin supplements, prostate cancer risk in men and mortality in women have yielded disappointing results. Some researchers remain optimistic about identifying dietary and lifestyle interventions that are beneficial to health.
October 19, 2011
A rekindled controversy over the use of PSA screening to help detect prostate cancer highlights the different perspectives physicians may take in framing issues, evaluating studies and deciding on best practices.
September 01, 2011
For the first time in his life, 50-year-old Art Wagner is growing a beard to raise awareness of prostate cancer after he was successfully treated at UCSF Medical Center. 
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
May 21, 2010
The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF.
July 27, 2009
June Chan, who specializes in the study of nutritional and hormonal risk factors for prostate cancer, has been named the Steven and Christine-Burd Safeway Endowed Chair.